article · Breast Cancer Research and Treatment
The abstract on record is too brief for a reliable plain-language summary, so none has been generated.
This study revealed that serum MIF levels may be regarded as a promising serum tumor marker for BC. Also, the rs1049829 variant of the MIF gene is considered a protective candidate against BC.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1007/s10549-024-07393-9
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
